We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 2,217 results

  3. Imipenem/cilastatin

    in Reactions Weekly
    Article 12 August 2023

  4. Imipenem/cilastatin

    in Reactions Weekly
    Article 22 April 2023

  5. In vitro study of the embolic characteristics of imipenem/cilastatin particles

    Background

    Imipenem/cilastatin (IPM/CS) has long been administered intravenously as a carbapenem antibiotic. However, since this agent is poorly...

    Hiroki Nakamura, Akira Yamamoto, ... Tsutomu Tamada in CVIR Endovascular
    Article Open access 11 March 2024

  9. Cilastatin/imipenem

    in Reactions Weekly
    Article 20 August 2022

  10. Imipenem/cilastatin

    in Reactions Weekly
    Article 11 June 2022

  12. Imipenem/cilastatin

    in Reactions Weekly
    Article 02 April 2022

  15. A Retrospective Comparison of the Efficacy of Embolization with Imipenem/Cilastatin and Microspheres in the Management of Chronic Shoulder Pain

    Purpose

    To compare the efficacy of embolization with imipenem/cilastatin and microspheres in chronic shoulder pain.

    Methods

    This retrospective study...

    Mathieu Finas, Julien Frandon, ... Julien Ghelfi in CardioVascular and Interventional Radiology
    Article 24 February 2023

  17. Transcatheter arterial embolization for acute lower gastrointestinal bleeding using imipenem/cilastatin: a single-center retrospective study

    Background

    Transcatheter arterial embolization (TAE) is a standard treatment for acute lower gastrointestinal bleeding (LGIB) in situations where...

    Sakiko Hiraki, Fumie Sato, ... Yoshiaki Ichinose in CVIR Endovascular
    Article Open access 10 March 2023

  19. Imipenem/cilastatin

    in Reactions Weekly
    Article 18 December 2021

  20. Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections

    Imipenem/cilastatin/relebactam (Recarbrio™) is an intravenously administered combination of the carbapenem imipenem, the renal dehydropeptidase-I...

    Young-A. Heo in Drugs
    Article 25 February 2021
Did you find what you were looking for? Share feedback.